Novo Nordisk A/S (NYSE:NVO)

47.14
Delayed Data
As of Apr 23
 -0.09 / -0.19%
Today’s Change
36.39
Today|||52-Week Range
58.37
-12.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues4.1B4.3B4.2B4.5B
 
 
 
 
 
Cost of Goods Sold510.3M533.0M567.3M604.7M
 
 
 
 
 
Depreciation And Amortization102.0M129.7M112.3M144.2M
 
 
 
 
 
 
Operating ExpensesGross Income3.5B3.6B3.6B3.7B
 
 
 
 
 
General Expenses1.6B1.7B1.7B2.1B
 
 
 
 
 
Research And Development473.7M513.2M529.4M634.7M
 
 
 
 
 
Total Operating Expenses2.2B2.3B2.4B2.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.9B2.0B1.8B1.6B
 
 
 
 
 
Interest Expense On Debt2.6M7.5M477.2K--
 
 
 
 
Other Expenses-27.4M-75.8M134.3M-123.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.9B1.9B2.0B1.7B
 
 
 
 
 
Income Taxes-410.2M-404.7M-428.2M-369.4M
 
 
 
 
 
Net Income1.5B1.5B1.6B1.3B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.59------
 
 
EPS Diluted$0.58$0.60$0.63$0.54